GCK-MODY: Mild, Stable, Untreated

GCK-MODY, also called MODY2, is the subtype that most changes how people think about their diagnosis — because the usual answer is that no treatment is needed.

The GCK gene makes glucokinase, the enzyme your beta cell uses to sense how much glucose is in your blood. With one altered copy, the sensor reads slightly high — so your body regulates glucose correctly, just around a slightly higher set point. It is a thermostat set two degrees warm rather than a broken heater.

The result is mild, stable raised fasting glucose, typically around 100 to 145 mg/dL, with little rise after meals and HbA1c usually below about 7.6%. People are generally asymptomatic. Crucially, it does not deteriorate with age the way Type 2 does.

Treatment for the raised glucose is described as almost always unnecessary and ineffective outside pregnancy — glucose-lowering tablets do not work well, because the set point is not a fault to be corrected.

The complication data is the striking part. In a UK comparison, clinically significant microvascular complications occurred in 1% of people with GCK-MODY against 36% of those with Type 2 diabetes, and macrovascular complications in 4% against 30%.

Pregnancy is the exception where treatment may be needed, and that decision depends on the baby's genotype.